{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:37:24Z","timestamp":1794620244682,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grants #31871201"],"award-info":[{"award-number":["Grants #31871201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31371060"],"award-info":[{"award-number":["31371060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Science and Technology Project of Henan Province of China","award":["No. 202102310222"],"award-info":[{"award-number":["No. 202102310222"]}]},{"name":"The Science and Technology Project of Henan Province of China","award":["No. 202102310419"],"award-info":[{"award-number":["No. 202102310419"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormal iron metabolism, mitochondrial dysfunction and the derived oxidative damage are the main pathogeneses of Friedrich's ataxia (FRDA), a single-gene inherited recessive neurodegenerative disease characterized by progressive cerebellar and sensory ataxia. This disease is caused by frataxin (<jats:italic>FXN<\/jats:italic>) mutation, which reduces FXN expression and impairs iron sulfur cluster biogenesis. To date, there is no effective therapy to treat this condition. Curcumin is proposed harboring excellent ability to resist oxidative stress through Nrf2 activation and its newly found ability to chelate iron. However, its limitation is its poor water solubility and permeability. Here, we synthesized slow-release nanoparticles (NPs) by loading curcumin (Cur) into silk fibroin (SF) to form NPs with an average size of 150\u00a0nm (Cur@SF NPs), which exhibited satisfactory therapeutic effects on the improvement of FRDA manifestation in lymphoblasts (1\u00a0\u03bcM) derived from FRDA patients and in YG8R mice (150\u00a0mg\/kg\/5\u00a0days). Cur@SF NPs not only removed iron from the heart and diminished oxidative stress in general but also potentiate iron-sulfur cluster biogenesis, which compensates FXN deficiency to improve the morphology and function of mitochondria. Cur@SF NPs showed a significant advantage in neuron and myocardial function, thereby improving FRDA mouse behavior scores. These data encourage us to propose that Cur@SF NPs are a promising therapeutic compound in the application of FRDA disease.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-022-01333-9","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:03:11Z","timestamp":1646823791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cur@SF NPs alleviate Friedreich\u2019s ataxia in a mouse model through synergistic iron chelation and antioxidation"],"prefix":"10.1186","volume":"20","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9738-049X","authenticated-orcid":false,"given":"Kuanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"1333_CR1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al. Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423\u20137.","journal-title":"Science"},{"key":"1333_CR2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.embor.embor918","volume":"4","author":"J Gerber","year":"2003","unstructured":"Gerber J, Muhlenhoff U, Lill R. An interaction between frataxin and Isu1\/Nfs1 that is crucial for Fe\/S cluster synthesis on Isu1. EMBO Rep. 2003;4:906\u201311.","journal-title":"EMBO Rep"},{"key":"1333_CR3","doi-asserted-by":"crossref","first-page":"103419","DOI":"10.1016\/j.mcn.2019.103419","volume":"102","author":"A Stepanova","year":"2020","unstructured":"Stepanova A, Magrane J. Mitochondrial dysfunction in neurons in Friedreich\u2019s ataxia. Mol Cell Neurosci. 2020;102:103419.","journal-title":"Mol Cell Neurosci"},{"key":"1333_CR4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-011-0844-9","volume":"122","author":"AH Koeppen","year":"2011","unstructured":"Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich\u2019s ataxia. Acta Neuropathol. 2011;122:323\u201330.","journal-title":"Acta Neuropathol"},{"key":"1333_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14734220600913246","volume":"5","author":"S Michael","year":"2006","unstructured":"Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD, Koeppen AH. Iron and iron-responsive proteins in the cardiomyopathy of Friedreich\u2019s ataxia. Cerebellum. 2006;5:257\u201367.","journal-title":"Cerebellum"},{"key":"1333_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","volume":"104","author":"AE Harding","year":"1981","unstructured":"Harding AE. Friedreich\u2019s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981;104:589\u2013620.","journal-title":"Brain"},{"key":"1333_CR7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","volume":"125","author":"F Weidemann","year":"2012","unstructured":"Weidemann F, Rummey C, Bijnens B, Stork S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T. Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome study g: The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation. 2012;125:1626\u201334.","journal-title":"Circulation"},{"key":"1333_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehq443","volume":"32","author":"SV Raman","year":"2011","unstructured":"Raman SV, Phatak K, Hoyle JC, Pennell ML, McCarthy B, Tran T, Prior TW, Olesik JW, Lutton A, Rankin C, et al. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur Heart J. 2011;32:561\u20137.","journal-title":"Eur Heart J"},{"key":"1333_CR9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mds.22864","volume":"25","author":"B Rajagopalan","year":"2010","unstructured":"Rajagopalan B, Francis JM, Cooke F, Korlipara LV, Blamire AM, Schapira AH, Madan J, Neubauer S, Cooper JM. Analysis of the factors influencing the cardiac phenotype in Friedreich\u2019s ataxia. Mov Disord. 2010;25:846\u201352.","journal-title":"Mov Disord"},{"key":"1333_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","volume":"27","author":"H Puccio","year":"2001","unstructured":"Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27:181\u20136.","journal-title":"Nat Genet"},{"key":"1333_CR11","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.M110.163253","volume":"286","author":"A Seguin","year":"2011","unstructured":"Seguin A, Santos R, Pain D, Dancis A, Camadro JM, Lesuisse E. Co-precipitation of phosphate and iron limits mitochondrial phosphate availability in Saccharomyces cerevisiae lacking the yeast frataxin homologue (YFH1). J Biol Chem. 2011;286:6071\u20139.","journal-title":"J Biol Chem"},{"key":"1333_CR12","doi-asserted-by":"crossref","first-page":"20590","DOI":"10.1073\/pnas.1215349109","volume":"109","author":"M Whitnall","year":"2012","unstructured":"Whitnall M, Suryo Rahmanto Y, Huang ML, Saletta F, Lok HC, Gutierrez L, Lazaro FJ, Fleming AJ, St Pierre TG, Mikhael MR, et al. Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proc Natl Acad Sci U S A. 2012;109:20590\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1333_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2019.02.001","volume":"40","author":"SY Zhang","year":"2019","unstructured":"Zhang SY, Napierala M, Napierala JS. Therapeutic prospects for Friedreich\u2019s ataxia. Trends Pharmacol Sci. 2019;40:229\u201333.","journal-title":"Trends Pharmacol Sci"},{"key":"1333_CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.24248","volume":"76","author":"M Pandolfo","year":"2014","unstructured":"Pandolfo M, Arpa J, Delatycki MB, Le Quan Sang KH, Mariotti C, Munnich A, Sanz-Gallego I, Tai G, Tarnopolsky MA, Taroni F, et al. Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann Neurol. 2014;76:509\u201321.","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"1333_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.12322","volume":"126","author":"MH Parkinson","year":"2013","unstructured":"Parkinson MH, Schulz JB, Giunti P. Co-enzyme Q10 and idebenone use in Friedreich\u2019s ataxia. J Neurochem. 2013;126(Suppl 1):125\u201341.","journal-title":"J Neurochem"},{"key":"1333_CR16","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","volume":"15","author":"L Feng","year":"2021","unstructured":"Feng L, Dou C, Xia Y, Li B, Zhao M, Yu P, Zheng Y, El-Toni AM, Atta NF, Galal A, et al. Neutrophil-like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery. ACS Nano. 2021;15:2263\u201380.","journal-title":"ACS Nano"},{"key":"1333_CR17","doi-asserted-by":"crossref","first-page":"119678","DOI":"10.1016\/j.biomaterials.2019.119678","volume":"231","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang K, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H. Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials. 2020;231:119678.","journal-title":"Biomaterials"},{"key":"1333_CR18","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.bioactmat.2021.01.016","volume":"6","author":"W Hou","year":"2021","unstructured":"Hou W, Ye C, Chen M, Gao W, Xie X, Wu J, Zhang K, Zhang W, Zheng Y, Cai X. Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis. Bioact Mater. 2021;6:2439\u201351.","journal-title":"Bioact Mater"},{"key":"1333_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12951-021-00897-2","volume":"19","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yin Y, Zhang W, Li H, Wang T, Yin H, Sun L, Su C, Zhang K, Xu H. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis. J Nanobiotechnology. 2021;19:161.","journal-title":"J Nanobiotechnology"},{"key":"1333_CR20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/biof.1063","volume":"39","author":"A Monroy","year":"2013","unstructured":"Monroy A, Lithgow GJ, Alavez S. Curcumin and neurodegenerative diseases. BioFactors. 2013;39:122\u201332.","journal-title":"BioFactors"},{"key":"1333_CR21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.freeradbiomed.2005.11.003","volume":"40","author":"Y Jiao","year":"2006","unstructured":"Jiao Y, Wilkinson JT, Christine Pietsch E, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006;40:1152\u201360.","journal-title":"Free Radic Biol Med"},{"key":"1333_CR22","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ptr.6658","volume":"34","author":"S Sharifi","year":"2020","unstructured":"Sharifi S, Fathi N, Memar MY, Hosseiniyan Khatibi SM, Khalilov R, Negahdari R, Zununi Vahed S, Maleki Dizaj S. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives. Phytother Res. 2020;34:1926\u201346.","journal-title":"Phytother Res"},{"key":"1333_CR23","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/acs.nanolett.8b04729","volume":"19","author":"K Zhang","year":"2019","unstructured":"Zhang K, Tu M, Gao W, Cai X, Song F, Chen Z, Zhang Q, Wang J, Jin C, Shi J, et al. Hollow prussian blue nanozymes drive neuroprotection against ischemic stroke via attenuating oxidative stress, counteracting inflammation, and suppressing cell apoptosis. Nano Lett. 2019;19:2812\u201323.","journal-title":"Nano Lett"},{"key":"1333_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202006581","author":"LS Feng","year":"2020","unstructured":"Feng LS, Dou CR, Xia YG, Li BH, Zhao MY, El-Toni AM, Atta NF, Zheng YY, Cai XJ, Wang Y, et al. Enhancement of nanozyme permeation by endovascular interventional treatment to prevent vascular restenosis via macrophage polarization modulation. Adv Funct Mater. 2020. https:\/\/doi.org\/10.1002\/adfm.202006581.","journal-title":"Adv Funct Mater"},{"key":"1333_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biomaterials.2018.08.044","volume":"183","author":"J Qu","year":"2018","unstructured":"Qu J, Zhao X, Liang Y, Zhang T, Ma PX, Guo B. Antibacterial adhesive injectable hydrogels with rapid self-healing, extensibility and compressibility as wound dressing for joints skin wound healing. Biomaterials. 2018;183:185\u201399.","journal-title":"Biomaterials"},{"key":"1333_CR26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41392-021-00830-x","volume":"6","author":"H Cao","year":"2021","unstructured":"Cao H, Duan L, Zhang Y, Cao J, Zhang K. Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther. 2021;6:426.","journal-title":"Signal Transduct Target Ther"},{"key":"1333_CR27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.carbpol.2016.08.046","volume":"155","author":"M Alibolandi","year":"2017","unstructured":"Alibolandi M, Mohammadi M, Taghdisi SM, Ramezani M, Abnous K. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017;155:218\u201329.","journal-title":"Carbohydr Polym"},{"key":"1333_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201905202","author":"Z Wang","year":"2019","unstructured":"Wang Z, Hao Z, Yu S, De Moraes CG, Suh LH, Zhao X, Lin Q. An Ultraflexible and Stretchable Aptameric Graphene Nanosensor for Biomarker Detection and Monitoring. Adv Funct Mater. 2019. https:\/\/doi.org\/10.1002\/adfm.201905202.","journal-title":"Adv Funct Mater"},{"key":"1333_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2015.03.020","volume":"206","author":"F Mottaghitalab","year":"2015","unstructured":"Mottaghitalab F, Farokhi M, Shokrgozar MA, Atyabi F, Hosseinkhani H. Silk fibroin nanoparticle as a novel drug delivery system. J Control Release. 2015;206:161\u201376.","journal-title":"J Control Release"},{"key":"1333_CR30","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1002\/adma.201403562","volume":"26","author":"Y Tian","year":"2014","unstructured":"Tian Y, Jiang X, Chen X, Shao Z, Yang W. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater. 2014;26:7393\u20138.","journal-title":"Adv Mater"},{"key":"1333_CR31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.colsurfb.2018.10.053","volume":"173","author":"L Zhang","year":"2019","unstructured":"Zhang L, Xu L, Li G, Yang Y. Fabrication of high-strength mecobalamin loaded aligned silk fibroin scaffolds for guiding neuronal orientation. Colloids Surf B Biointerfaces. 2019;173:689\u201397.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1333_CR32","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.1073\/pnas.1820051116","volume":"116","author":"H Li","year":"2019","unstructured":"Li H, Liu Y, Shang L, Cai J, Wu J, Zhang W, Pu X, Dong W, Qiao T, Li K. Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts. Proc Natl Acad Sci U S A. 2019;116:9871\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1333_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab232","author":"Y Liu","year":"2021","unstructured":"Liu Y, Cai J, Shen J, Dong W, Xu L, Fang M, Lin Y, Liu J, Ding Y, Qiao T, Li K. SS-31 efficacy in a mouse model of Friedreich ataxia by upregulation of frataxin expression. Hum Mol Genet. 2021. https:\/\/doi.org\/10.1093\/hmg\/ddab232.","journal-title":"Hum Mol Genet"},{"key":"1333_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2019.111805","author":"A Beneduci","year":"2019","unstructured":"Beneduci A, Corrente GA, Marino T, Aiello D, Bartella L, Di Donna L, Napoli A, Russo N, Romeo I, Furia E. Insight on the chelation of aluminum(III) and iron(III) by curcumin in aqueous solution. J Mol Liq. 2019. https:\/\/doi.org\/10.1016\/j.molliq.2019.111805.","journal-title":"J Mol Liq"},{"key":"1333_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0234-y","author":"NE Rainey","year":"2019","unstructured":"Rainey NE, Moustapha A, Saric A, Nicolas G, Sureau F, Petit PX. Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation. Cell Death Discov. 2019. https:\/\/doi.org\/10.1038\/s41420-019-0234-y.","journal-title":"Cell Death Discov"},{"key":"1333_CR36","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.3390\/molecules191220091","volume":"19","author":"KI Priyadarsini","year":"2014","unstructured":"Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19:20091\u2013112.","journal-title":"Molecules"},{"key":"1333_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110528","author":"YX Sun","year":"2019","unstructured":"Sun YX, Shi FF, Niu YJ, Zhang Y, Xiong F. Fe3O4@OA@Poloxamer nanoparticles lower triglyceride in hepatocytes through liposuction effect and nano-enzyme effect. Colloids Surf B-Biointerfaces. 2019. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.110528.","journal-title":"Colloids Surf B-Biointerfaces"},{"key":"1333_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.132303","author":"Y Sun","year":"2022","unstructured":"Sun Y, Xu L, Liu X, Shen Y, Zhang Y, Gu N, Xiong F. Coronal relay reactor Fe3O4@CeO2 for accelerating ROS axial conversion through enhanced Enzyme-like effect and relay effect. Chem Eng J. 2022. https:\/\/doi.org\/10.1016\/j.cej.2021.132303.","journal-title":"Chem Eng J"},{"key":"1333_CR39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pneurobio.2007.06.001","volume":"82","author":"S Mandel","year":"2007","unstructured":"Mandel S, Amit T, Bar-Am O, Youdim MBH. Iron dysregulation in Alzheimer\u2019s disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Prog Neurobiol. 2007;82:348\u201360.","journal-title":"Prog Neurobiol"},{"key":"1333_CR40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","volume":"8","author":"SK Tiwari","year":"2014","unstructured":"Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, Karmakar M, Kumari M, Chauhan LKS, Patel DK, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in alzheimer\u2019s disease model via canonical wnt\/beta-catenin pathway. ACS Nano. 2014;8:76\u2013103.","journal-title":"ACS Nano"},{"key":"1333_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtemb.2014.12.012","volume":"31","author":"RJ Ward","year":"2015","unstructured":"Ward RJ, Dexter DT, Crichton RR. Neurodegenerative diseases and therapeutic strategies using iron chelators. J Trace Elem Med Biol. 2015;31:267\u201373.","journal-title":"J Trace Elem Med Biol"},{"key":"1333_CR42","doi-asserted-by":"crossref","first-page":"e107416","DOI":"10.1371\/journal.pone.0107416","volume":"9","author":"S Anjomani Virmouni","year":"2014","unstructured":"Anjomani Virmouni S, Sandi C, Al-Mahdawi S, Pook MA. Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia. PLoS ONE. 2014;9:e107416.","journal-title":"PLoS ONE"},{"key":"1333_CR43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bioactmat.2021.08.012","volume":"10","author":"Y Sun","year":"2022","unstructured":"Sun Y, Liu X, Wang L, Xu L, Liu K, Xu L, Shi F, Zhang Y, Gu N, Xiong F. High-performance SOD mimetic enzyme Au@Ce for arresting cell cycle and proliferation of acute myeloid leukemia. Bioact Mater. 2022;10:117\u201330.","journal-title":"Bioact Mater"},{"key":"1333_CR44","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.7150\/thno.52010","volume":"11","author":"X Xie","year":"2021","unstructured":"Xie X, Zhao J, Gao W, Chen J, Hu B, Cai X, Zheng Y. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs\/NF-kappaB signaling pathway. Theranostics. 2021;11:3213\u201328.","journal-title":"Theranostics"},{"key":"1333_CR45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-020-01628-5","volume":"39","author":"A Garufi","year":"2020","unstructured":"Garufi A, Baldari S, Pettinari R, Gilardini Montani MS, D\u2019Orazi V, Pistritto G, Crispini A, Giorno E, Toietta G, Marchetti F, et al. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death\/survival outcome according to p53 status. J Exp Clin Cancer Res. 2020;39:122.","journal-title":"J Exp Clin Cancer Res"},{"key":"1333_CR46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41401-020-0443-1","volume":"42","author":"CS Ma","year":"2021","unstructured":"Ma CS, Lv QM, Zhang KR, Tang YB, Zhang YF, Shen Y, Lei HM, Zhu L. NRF2-GPX4\/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells. Acta Pharmacol Sin. 2021;42:613\u201323.","journal-title":"Acta Pharmacol Sin"},{"key":"1333_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216711","author":"XY Lin","year":"2019","unstructured":"Lin XY, Bai DP, Wei ZX, Zhang Y, Huang YF, Deng H, Huang XH. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0216711.","journal-title":"PLoS ONE"},{"key":"1333_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.52601\/bpr.2021.200038","volume":"7","author":"W Zhang","year":"2021","unstructured":"Zhang W, Xu L, Zhao H, Li K. Mammalian mitochondrial iron\u2013sulfur cluster biogenesis and transfer and related human diseases. Biophysics Reports. 2021;7:127\u201341.","journal-title":"Biophysics Reports"},{"key":"1333_CR49","doi-asserted-by":"crossref","first-page":"104606","DOI":"10.1016\/j.nbd.2019.104606","volume":"132","author":"MB Delatycki","year":"2019","unstructured":"Delatycki MB, Bidichandani SI. Friedreich ataxia- pathogenesis and implications for therapies. Neurobiol Dis. 2019;132:104606.","journal-title":"Neurobiol Dis"},{"key":"1333_CR50","doi-asserted-by":"publisher","DOI":"10.1042\/NS20200093","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Farmer G. Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions. Neuronal Signal. 2021. https:\/\/doi.org\/10.1042\/NS20200093.","journal-title":"Neuronal Signal"},{"key":"1333_CR51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, Boesch S, Nachbauer W, Mariotti C, Mathews KD, et al. Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe Study). Ann Neurol. 2021;89:212\u201325.","journal-title":"Ann Neurol"},{"key":"1333_CR52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-981-13-9589-5_7","volume":"1173","author":"K Li","year":"2019","unstructured":"Li K. Iron pathophysiology in Friedreich\u2019s ataxia. Adv Exp Med Biol. 2019;1173:125\u201343.","journal-title":"Adv Exp Med Biol"},{"key":"1333_CR53","doi-asserted-by":"crossref","first-page":"113820","DOI":"10.1016\/j.bcp.2020.113820","volume":"173","author":"JW Shin","year":"2020","unstructured":"Shin JW, Chun KS, Kim DH, Kim SJ, Kim SH, Cho NC, Na HK, Surh YJ. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification. Biochem Pharmacol. 2020;173:113820.","journal-title":"Biochem Pharmacol"},{"key":"1333_CR54","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.2147\/IJN.S327737","volume":"16","author":"Y Yan","year":"2021","unstructured":"Yan Y, Chen Y, Liu Z, Cai F, Niu W, Song L, Liang H, Su Z, Yu B, Yan F. Brain delivery of curcumin through low-intensity ultrasound-induced blood-brain barrier opening via lipid-PLGA nanobubbles. Int J Nanomedicine. 2021;16:7433\u201347.","journal-title":"Int J Nanomedicine"},{"key":"1333_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00866-9","author":"W Zhao","year":"2021","unstructured":"Zhao W, Yu XR, Peng SJ, Luo Y, Li JC, Lu LG. Construction of nanomaterials as contrast agents or probes for glioma imaging. J Nanobiotechnol. 2021. https:\/\/doi.org\/10.1186\/s12951-021-00866-9.","journal-title":"J Nanobiotechnol"},{"key":"1333_CR56","doi-asserted-by":"crossref","first-page":"e2003458","DOI":"10.1002\/adma.202003458","volume":"33","author":"J Li","year":"2021","unstructured":"Li J, Yu X, Jiang Y, He S, Zhang Y, Luo Y, Pu K. Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced cancer immunotherapy. Adv Mater. 2021;33:e2003458.","journal-title":"Adv Mater"},{"key":"1333_CR57","doi-asserted-by":"crossref","first-page":"11251","DOI":"10.1021\/acsami.9b02401","volume":"11","author":"Y Fang","year":"2019","unstructured":"Fang Y, Li HY, Yin HH, Xu SH, Ren WW, Ding SS, Tang WZ, Xiang LH, Wu R, Guan X, Zhang K. Radiofrequency-sensitive longitudinal relaxation tuning strategy enabling the visualization of radiofrequency ablation intensified by magnetic composite. ACS Appl Mater Interfaces. 2019;11:11251\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1333_CR58","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/biof.1533","volume":"45","author":"A Bhat","year":"2019","unstructured":"Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, Padamati J, Chandra R, Chidambaram SB, Sakharkar MK. Benefits of curcumin in brain disorders. BioFactors. 2019;45:666\u201389.","journal-title":"BioFactors"},{"key":"1333_CR59","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3233\/JAD-170093","volume":"60","author":"JR Sundaram","year":"2017","unstructured":"Sundaram JR, Poore CP, Sulaimee NHB, Pareek T, Cheong WF, Wenk MR, Pant HC, Frautschy SA, Low CM, Kesavapany S. Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p25 transgenic mouse model that bears hallmarks of Alzheimer\u2019s disease. J Alzheimers Dis. 2017;60:1429\u201342.","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01333-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01333-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01333-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:13:09Z","timestamp":1646824389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01333-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01333-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care conformed to institutional guidelines. All animal studies were approved by the Institutional Ethics Committee of Nanjing University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest were disclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}